SMITHS FALLS, ON, Oct. 23, 2017 /CNW/ - Tweed Inc. (Tweed),
wholly-owned subsidiary of Canopy Growth Corporation ("Canopy
Growth" or the "Company") and DNA Holding LLC ("DNA Genetics" or
"DNA" or "Don and Aaron" or "The Guys") are proud to announce the
renewal and expansion of their partnership through to October 2022. Together they are committed to
bringing the best possible cannabis to Canada. Tweed and DNA's collaboration
sees DNA's world-renowned cannabis genetics exclusively grown and
sold in Canada by Tweed.
"Tweed is going strong with DNA and we're excited to keep the
momentum going into the adult-use market," said Mark Zekulin, President, Canopy Growth. "The
success we've had together will only build once we can introduce
the quality, care and precision of the DNA Certified product
line to recreational consumers."
When a cannabis product is DNA Certified it means it's
been grown using DNA genetics, phenotyped by the DNA team, and
produced to DNA's discerning standards under the watchful eye of
both DNA and Tweed in the best facilities in the world.
DNA's approach to selecting only the best has led to over 200
global cannabis awards, making them the most awarded cannabis
breeders in the world and a global powerhouse for breeding and
growing truly best-in-class strains. Tweed's e-commerce platform,
tweedmainstreet.com, is the only place in Canada to carry DNA Certified products. These
unique strains are the results of years of hard work and dedication
to their craft.
"Adult choice cannabis is getting closer and closer and this
partnership shows Tweed's commitment to making sure the future of
legal cannabis in Canada is seeded
in the heart and soul of people from the industry who truly
care about the plant. DNA Genetics are happy to be a part of the
transition into a legal Canadian market and partner with a team
who's able to get our heart and soul out to the people."
As a part of the related compensation package, DNA may be issued
79,717 common shares in the Company subject to achieving certain
milestones.
DNA and Tweed are also pleased to expand this exclusive
licensing relationship into Jamaica, where, so long as federally legal,
Tweed and DNA will work similarly in the medical market to
cultivate the best possible cannabis genetics.
Here's to Future (Breeding, Phenotyping, Hyperosmia,
Certification, and) Growth.
About Canopy Growth Corporation
Canopy Growth is a
world-leading diversified cannabis company, offering distinct
brands and curated cannabis varieties in dried, oil and capsule
forms. Through its wholly‑owned subsidiaries, Canopy Growth
operates numerous state-of-the-art production facilities with over
half a million square feet of GMP-certified indoor and greenhouse
production capacity, all to an unparalleled level of quality
assurance procedures and testing. Canopy Growth has established
partnerships with leading sector names in Canada and abroad, with interests and
operations spanning four continents. The Company is proudly
dedicated to educating healthcare practitioners, providing
consistent access to high quality cannabis products, conducting
robust clinical research, and furthering the public's understanding
of cannabis. For more information visit www.canopygrowth.com.
Notice Regarding Forward Looking Statements
This news
release contains forward-looking statements. Often, but not always,
forward-looking statements can be identified by the use of words
such as "plans", "expects" or "does not expect", "is expected",
"estimates", "intends", "anticipates" or "does not anticipate", or
"believes", or variations of such words and phrases or state that
certain actions, events or results "may", "could", "would", "might"
or "will" be taken, occur or be achieved. Forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause the actual results, performance or
achievements of Canopy Growth Corporation, Tweed Inc., Tweed Farms
Inc. or Bedrocan Canada Inc. to be materially different from any
future results, performance or achievements expressed or implied by
the forward-looking statements. Examples of such statements include
future operational and production capacity, the impact of enhanced
infrastructure and production capabilities, and forecasted
available product selection. The forward-looking statements
included in this news release are made as of the date of this news
release and Canopy Growth Corp. does not undertake an obligation to
publicly update such forward-looking statements to reflect new
information, subsequent events or otherwise unless required by
applicable securities legislation.
Neither the TSX Exchange nor its Regulation Services Provider
(as that term is defined in policies of the TSX Exchange) accepts
responsibility for the adequacy or accuracy of this release.
SOURCE Canopy Growth Corporation